Portulaca oleracea L. extract ameliorates the cisplatin-induced toxicity in chick embryonic liver

Indian Journal of Biochemistry and Biophysics

Volumn 47, Issue 3, 2010, Pages 185-189

  Sudhakar, D ^a   Kishore, R Krishna ^a   Parthasarathy, P R ^a  

^a SRI VENKATESWARA UNIVERSITY   (India)

Author keywords

Antioxidants; Chick embryo; Cisplatin; Hepatotoxicity; Lipid peroxidation; Liver tissue; Portulaca oleracea L.

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CISPLATIN; PLANT EXTRACT;

ANIMAL; ARTICLE; CHICK EMBRYO; DRUG ANTAGONISM; DRUG EFFECT; LIPID PEROXIDATION; LIVER; METABOLISM; PHYTOTHERAPY; PORTULACACEAE; PRENATAL DEVELOPMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CHICK EMBRYO; CISPLATIN; LIPID PEROXIDATION; LIVER; PHYTOTHERAPY; PLANT EXTRACTS; PORTULACA;

ANIMALIA; PORTULACA OLERACEA;

EID: 77954296374     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Sleijfer D T, Meijer S & Mulder R N H (1985) Pharmaceut Weekblad Scient Edn 7, 227-237
2. Thigpen T, Vance R, Puneky L & Khansurt T (1994) Gynecol Oncol 55, 597-607
3. Rosenberg B (1977) Adv Exp Med Biol 91, 129-150
4. Hill J M & Speer R J (1982) Anticancer Res 2, 173-186
5. Hamilton J W, Denison M S & Bloom S E (1983) Proc Natl Acad Sci (USA) 80, 3372-3376
6. Gamett D C & Klein N W (1984) Teratog Carcinog Mutag 4, 245-257
7. Brunstrom B (1986) Xenobiotika 9, 865-872
8. Leung, A Y & Foster S (1996) Encyclopedia of Common Natural Ingredients used in Food, Drugs and Cosmetics, 2nd edn., John Wiley
9. Sakai N, Inada K, Okamoto M, Shizuri Y & Fukuyama Y (1996) Phytochemistry 42, 1625-1628.
10. Zhang X J, Ji Y B, Qu Zh Y, Xia J Ch & Wang L (2002) Chin J Microecol 14, 277-280
11. Xiang L, Xing D, Wang W, Wang R, Ding Y & Du L (2005) Phytochemistry 66, 2595-2601
12. Li F, Li Q, Gao D, Peng Y & Feng C (2009) Afr J Biotechnol 8, 569-573
13. Chen Cheng-Jie, Wang Wan-Yin, Wang Xiao-Li, Dong Li-Wei, Yue Yi-Tian, Xin Hai-Liang, Ling Chang-Quan & Li Min (2009) J Ethnopharmacol 124, 246-250
14. Sanja S D, Sheth N R, Patel N K, Dhaval P & Biraju P (2009) Int J Pharmacy Pharma Sci 1, 74-84
15. Rashed A N, Afifi Fu & Disi A M (2003) J Ethnopharmacol 88, 136-141
16. King J C (1965a) Practical Clinical Enzymology (Princeton M J, ed), pp 264-265, 363-365, Van D Nostrand Co., London
17. Misra H P & Fridovich I (1972) J Biol Chem 247, 3170-3175
18. Aebi H (1984) Meth Enzymol 105, 121-126
19. Wendel A (1981) Meth Enzymol 77, 325-333
20. Staal G E, Visser J & Veeger C (1969) Biochem Biophys Acta 185, 39-48
21. Habig W H, Pabst M J & Jakoby W B (1974) J Biol Chem 249, 7130-7139
22. Moron M S, Depierre J W & Mannervik B (1979) Biochem Biophys Acta 582, 67-78
23. Ohkawa H, Ohishi N & Yagi K (1979) Anal Biochem 95, 351-358
24. Bhakta T, Mukherjee P K & Mukherjee K (1999) J Ethnopharmacol 66, 227-231
25. Sherlock S & Dooley J (1993) Assessment of liver function, in diseases of the liver and biliary system, Vol. 9, pp 17-26, Oxford Blackwell Scientific Publications, London
26. Simopoulos Artemis P (2004) Biol Res 37, 263-277
27. Dragsted L O, Strube M & Leth T (1997) Envr J Cancer Prev 6, 522-528
28. Akyol O, Herken H, Uz E, Fadillioglu E, Unal S, Sogut SO, Zyurt H & Savas H A (2002) Prog Neuropsychopharmacol Bio Psych 26, 995-1005
29. Shimeda Y, Hirotani Y, Akimoto Y, Shindou K, Ijiri Y, Nishihori T & Tanaka K (2005) Biol Pharm Bull 28, 1635-1638
30. Aslihan A V C I, Cetin R, Erguder I B, Devrim E, Kilicoglu B, Candir O, Ozturk H S & Durak I (2008) Turk J Med Sci 38, 117-120
31. Liebau E, Wildenburg G, Walter R D, Henkle-Duhrsen K (1994) Infect Immun 62, 4762-4767
32. Masella R, Di Benedetto R, Var Filesi C & Giovannini C (2005) J Nutr Biochem 16, 577-586
33. Zhang J G & Lindup W E (1993) Biochem Pharmacol 45, 2215-2222
34. MillerT E, Wing, J S & Huete A (1984) J Arid Environ 7, 275-286
35. Halim A B, El-Ahmady O, Hassab-Allah S, Abdel-Galil F, Hafez Y & Darwish A (1997) Ann Clin Biochem 34, 656-663